Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Divestments (2016 - 2025)

Surgery Partners' Divestments history spans 8 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Divestments rose 150.0% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $2.1 million, up 5.0%, while the annual FY2025 figure was $1.5 million, 67.39% down from the prior year.
  • Divestments for Q4 2025 was $1.5 million at Surgery Partners, up from $600000.0 in the prior quarter.
  • Across five years, Divestments topped out at $11.5 million in Q1 2022 and bottomed at $400000.0 in Q4 2023.
  • The 5-year median for Divestments is $1.3 million (2022), against an average of $3.1 million.
  • The largest annual shift saw Divestments crashed 75.93% in 2022 before it skyrocketed 150.0% in 2025.
  • A 5-year view of Divestments shows it stood at $5.4 million in 2021, then plummeted by 75.93% to $1.3 million in 2022, then crashed by 69.23% to $400000.0 in 2023, then soared by 50.0% to $600000.0 in 2024, then surged by 150.0% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Divestments are $1.5 million (Q4 2025), $600000.0 (Q4 2024), and $400000.0 (Q4 2023).